Journal article
Efficacy and safety of Mitoxantrone, as an initial therapy, in multiple sclerosis: Experience in an Indian tertiary care setting
Abstract
BACKGROUND AND PURPOSE: Mitoxantrone is an approved disease modifying agent for treatment of multiple sclerosis (MS). The aim of the study was to assess its efficacy and safety in Indian MS patients.
MATERIALS AND METHODS: A total of 23 patients with clinically definite MS (Poser criteria) were enrolled in an open label study. Of which, 21 satisfied the McDonald's criteria for MS and two satisfied the diagnostic criteria of neuromyelitis optica …
Authors
Singhal B; Geeta S; Hundalani SG; Menon S
Journal
Neurology India, Vol. 57, No. 4, pp. 418–423
Publisher
Wolters Kluwer
Publication Date
2009
DOI
10.4103/0028-3886.55611
ISSN
0028-3886